Agena Bioscience Eyes New Year Target For Mass Spec Liquid Biopsy Launch
Executive Summary
Agena Bioscience will launch two diagnostic panels for targeted testing of lung and colon cancer in Europe in January. The liquid biopsy technology is based on its benchtop mass spectrometer, the MassArray Dx Analyzer 4.